1. Home
  2. NXPL vs ONMD Comparison

NXPL vs ONMD Comparison

Compare NXPL & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextPlat Corp

NXPL

NextPlat Corp

N/A

Current Price

$8.88

Market Cap

23.1M

ML Signal

N/A

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$0.68

Market Cap

42.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXPL
ONMD
Founded
1997
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
23.1M
42.1M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
NXPL
ONMD
Price
$8.88
$0.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
43.4K
283.3K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
35.29
83.33
EPS
N/A
N/A
Revenue
$5,869,558.00
$1,359,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.50
111.35
52 Week Low
$0.34
$0.49
52 Week High
$9.94
$4.22

Technical Indicators

Market Signals
Indicator
NXPL
ONMD
Relative Strength Index (RSI) 61.36 53.58
Support Level $5.54 $0.58
Resistance Level N/A $0.79
Average True Range (ATR) 0.59 0.04
MACD -0.09 0.01
Stochastic Oscillator 43.74 71.22

Price Performance

Historical Comparison
NXPL
ONMD

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

Share on Social Networks: